載入...
RBPJ maintains brain tumor–initiating cells through CDK9-mediated transcriptional elongation
Glioblastomas co-opt stem cell regulatory pathways to maintain brain tumor–initiating cells (BTICs), also known as cancer stem cells. NOTCH signaling has been a molecular target in BTICs, but NOTCH antagonists have demonstrated limited efficacy in clinical trials. Recombining binding protein suppres...
Na minha lista:
| 發表在: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Clinical Investigation
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4922685/ https://ncbi.nlm.nih.gov/pubmed/27322055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI86114 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|